iSTAR Medical SA news
WAVRE, Belgium — 6 September 2022: iSTAR Medical, a medtech company delivering breakthrough eye care solutions to patients, today announces the appointment of Dr Kaweh Mansouri as Chief Medical Officer (CMO).
Dr Mansouri is a medical and surgical eye specialist, sub-specializing in glaucoma and cataract. Currently a Consultant Ophthalmologist at the Glaucoma Center, Swiss Visio, Clinique de Montchoisi, and an Adjoint Professor at
NORTH CHICAGO, Ill. and WAVRE, BELGIUM, July 20, 2022 – AbbVie (NYSE: ABBV) and iSTAR Medical SA, today announced a strategic transaction to further develop and commercialize iSTAR Medical’s MINIject® device, a next-generation minimally invasive glaucoma surgical (MIGS) device for patients with glaucoma. This complementary alliance will support iSTAR Medical’s development and commercial efforts for MINIject®,
We will be in Nuremberg next week at the DOC congress where Prof. Dr med. Marc Schargus (Asklepios Klinik Nord, Hamburg) will be presenting a meta-analysis from the STAR-I, STAR-II and STAR-III trials on patients with open-angle glaucoma who consistently achieve low diurnal intraocular pressures (IOP) of ≤18 mmHg up to two-years after implantation with MINIject. The Advanced Glaucoma Intervention Study (AGIS, American Journal of Ophthalmology, 2000) concluded that consistent levels o
- Analysis provides further validation of MINIject®’s meaningful and sustained efficacy in open angle glaucoma patients
- No safety concerns with corneal endothelial health reported across all three trials
- MINIject® delivers positive, consistent results up to two-year follow-up in patients across Central and South America, Asia and Europe
WAVRE, Belgium — 8 June 2022
- The only commercially available MIGS device currently targeting the supraciliary space now available to patients and surgeons in Switzerland
- First implantations performed by Prof. Dr Kaweh Mansouri at Swiss Visio, Clinique de Montchoisi, Lausanne and Prof. Dr med. Jan Darius Unterlauft at Inselspital, Bern
WAVRE, Belgium — 10 May 2022: iSTAR Medical, a medtech company deliver